newsfilter
← Latest News
GlobeNewswire·

Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine to Present Phase 1 Clinical Data for KUR-501, an autologous GD2 CAR-NKT Cell Therapy for Relapsed/Refractory High Risk Neuroblastoma at the ASGCT 25th Annual Meeting

Data presented by investigators from the Texas Children's Cancer Center's Center for Advanced Innate Cell Therapy and Baylor College of Medicine Data demonstrate expansion of CAR-NKT cells post-transfer in all patients, and objective responses in pati